PRQR - ProQR Therapeutics NV Qarzning balans kapitallashuviga nisbati

proqr.com (PRQR) tovar belgisi

Geopolitik keskinliklar va sanksiyalar global gen terapiyasi sinovlariga jiddiy to'sqinlik qilmoqda, bu holat 0.17 darajasidagi ko'rsatkichda aks etgan. ProQR Therapeutics N.V. (PRQR) genetik xatolarni aniq tuzatish uchun himoyalangan patent tizimini ishlab chiqqan holda, Axiomer platformasiga tayanadi. Aksiyalar narxining harakati aks etgan ushbu grafik dozalashda inson omili xatolarini bartaraf etuvchi avtomatlashtirilgan oligonucleotid sintezi tizimlarining joriy etilishi bo'yicha ma'lumotlar bilan to'ldirilgan.

ProQR (PRQR): Qarzning sof aktivlarga nisbati 04.07.2022dan 28.10.2026gacha

proqr.com (PRQR) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi ProQR Therapeutics|PRQR - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati PRQR|PRQR - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar ProQR Therapeutics N.V.|PRQR - Kompaniyaning buxgalteriya qiymati|Bozor qiymatining balans qiymatiga nisbati proqr.com|PRQR - Kompaniya aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati ProQR Therapeutics N.V.|PRQR - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati ProQR Therapeutics|PRQR - Jamlangan qarz majburiyatlari|Qarzning balans qiymatiga nisbati PRQR
Kompaniyaning barcha koʻrsatkichlari tahlili:PRQR, ProQR Therapeutics NV
ProQR Therapeutics tayyor mahsulotlari

Ushbu ko'rsatkich kreditga layoqatlilik va defolt xavfini baholash uchun umumiy majburiyatlarni kapitalga nisbatan solishtirish orqali moliyaviy leveraj darajasini o'lchaydi. ProQR Therapeutics N.V. (PRQR) ning moliyaviy qarzi va balans kapitali nisbatini tahlil qilish orqali, investor ProQR Therapeutics N.V. (PRQR) o'z aktivlariga kritik qarz yukini yaratmasdan, RNA tahrirlash ishlanmalari va Eli Lilly bilan hamkorligini qanchalik samarali moliyalashtirayotganini baholashi mumkin.

ProQR Therapeutics N.V. (PRQR) raqobatchilari

Balans kapitallashuviga qarzlar TEM (Tempus AI Inc)|qiagen.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Ionis|RGEN: Qarzlarning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati Avidity RNA|CRSP (CRISPR) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati WGS (GeneDx Holdings Corp.)|Balans qiymatiga qarzlar RARE|BEAM: Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati SRPT (Sarepta Therapeutics)|Qarzning balans kapitallashuviga nisbati Twist Bio|TXG - Qarzning sof aktivlarga nisbati|Qarzning balans qiymatiga nisbati Intellia Therapeutics (NTLA)|stoketherapeutics.com (STOK) - Qarzning sof aktivlarga nisbati|BLFS - Qarzning balans qiymatiga nisbati|Wave Life Sciences Ltd (WVE) - Qarzning balans kapitaliga nisbati|MAZE - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Sionna Corp|Prime Medicine, Inc. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar TSHA (tayshagtx.com)|Qarzning balans kapitallashuviga nisbati uniQure|Qarzning sof aktivlarga nisbati MeiraGTx Holdings MGTX|Regenxbio - Balans kapitallashuviga qarzlar|SLDB: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Ocugen, Inc. (OCGN)|pacb.com (PACB) - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar BNTC (Benitec Biopharma)|Balans qiymatiga qarzlar Design Therapeutics Inc (DSGN)|Qarzning balans qiymatiga nisbati RCKT|Balans kapitallashuviga qarzlar 4D Molecular Corp FDMT|Qarzning balans qiymatiga nisbati Lexeo Therapeutics, Inc. (LXEO)|Qarzning balans kapitaliga nisbati Korro Bio Inc. KRRO|Balans kapitallashuviga qarzlar EDIT (Editas Medicine)|SLN - Sof aktivlarga qarzlar|CDXS (codexis.com) - Balans kapitallashuviga qarzlar|SGMO (Sangamo BioSciences) - Qarzning balans qiymatiga nisbati|NAUT: Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar metagenomi.co (MGX)|Precision BioSciences, Inc. (DTIL) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati GBIO (generationbio.com)|BOLD - Qarzning balans kapitallashuviga nisbati|XCUR - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati IMNN (Celsion Corporation)|Phio Pharmaceuticals (PHIO) - Sof aktivlarga qarzlar|mustangbio.com (MBIO) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati TransCode Therapeutics, Inc.|BNGO: Qarzning balans qiymatiga nisbati|Sof aktivlarga qarzlar APDN|BLUE - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati IPA (immunoprecise.com)|Qarzning balans kapitallashuviga nisbati Omega Therapeutics, Inc.|Singular Genomics Systems, Inc. - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati RGLS|SYRS: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Telesis Bio, Inc. TBIO|traconpharma.com (TCON) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar Unity Biotechnology, Inc. (UBX)